
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.780 | 0.780 | 0.000 |
Shares | 99.220 | 99.220 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.523 | 15.032 |
Price to Book | 1.834 | 2.116 |
Price to Sales | 1.144 | 1.740 |
Price to Cash Flow | 10.059 | 11.870 |
Dividend Yield | 2.373 | 2.810 |
5 Years Earnings Growth | 10.662 | 7.898 |
Name | Net % | Category Average |
---|---|---|
Industrials | 48.550 | 39.977 |
Financial Services | 19.190 | 20.680 |
Healthcare | 11.380 | 9.989 |
Technology | 6.340 | 8.670 |
Consumer Cyclical | 5.010 | 5.802 |
Consumer Defensive | 4.800 | 4.800 |
Real Estate | 3.410 | 4.402 |
Communication Services | 1.310 | 3.957 |
Number of long holdings: 28
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Volvo B | SE0000115446 | 9.04 | 276.20 | -0.72% | |
Atlas Copco A | SE0017486889 | 8.57 | 163.9 | +1.02% | |
SEB A | SE0000148884 | 7.42 | 159.50 | +0.95% | |
Investor B | SE0015811963 | 6.89 | 293.8 | +0.69% | |
Hexagon B | SE0015961909 | 6.30 | 100.93 | +0.00% | |
ASSA ABLOY B | SE0007100581 | 4.83 | 309.3 | +0.26% | |
Sandvik AB | SE0000667891 | 4.81 | 217.80 | +0.93% | |
AAK | SE0011337708 | 4.77 | 253.8 | -0.24% | |
AstraZeneca | GB0009895292 | 4.08 | 10,160.0 | +1.38% | |
Epiroc A | SE0015658109 | 3.81 | 224.50 | +0.36% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Enter Smabolagsfond A | 2.85B | -1.19 | -1.50 | - | ||
Enter Smabolagsfond B | 2.85B | -0.95 | -0.76 | - | ||
Enter Select | 2.61B | -0.81 | 4.20 | 6.44 | ||
Enter Sverige Pro | 335.04M | 7.47 | -0.95 | 9.38 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review